We are live on ! Find out more
PLXP

PLx Pharma Inc. Common Stock
PLXP

Delisted

PLXP was delisted on the 12th of April, 2023.

Back to rankings

1 hedge funds and large institutions have $0 invested in PLx Pharma Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% less funds holding

Funds holding: 4 → 1 (-3)

100% less capital invested

Capital invested by funds: $161 → $0 (-$161)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
1
Holders Change
-3
Holders Change %
-75%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SPIA
Steward Partners Investment Advisory
New York
-$123
2
BBA
Baader Bank Aktiengesellschaft
Germany
-$38
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
1
Steward Partners Investment Advisory
New York
– -$123 -43,875 Closed
BBA
2
Baader Bank Aktiengesellschaft
Germany
– -$38 -17,608 Closed

PLXP Hedge Fund Activity: Q3 2023 in Review

1 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q3 2023, worth a combined $0 — down 100% from $161 a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PLXP and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.

The largest seller was Steward Partners Investment Advisory, exiting entirely with an estimated $123 sold.

  • 1 institutional investor held PLx Pharma Inc. Common Stock (PLXP) as of Q3 2023, down from 4 in Q2 2023.
  • Funds reported $0 of PLx Pharma Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new PLx Pharma Inc. Common Stock positions in Q3 2023 and 3 closed out, a net change of -3 holders.
  • The largest PLx Pharma Inc. Common Stock seller in Q3 2023 was Steward Partners Investment Advisory, an estimated $123 sold.

Based on aggregated 13F filings for Q3 2023.